SNK-396
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SNK-396, covering 2024-06-21 to 2024-06-21. Get the full timeline:
Most recent: Clinical Trial Update: Dose Escalation of SNK-396 in Participants With Elevated Low-Density Lipoprotein Cholesterol [Phase 1]